Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Genotyping Market, by Product
1.4.2 North America Genotyping Market, by Application
1.4.3 North America Genotyping Market, by End Use
1.4.4 North America Genotyping Market, by Technology
1.4.5 North America Genotyping Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Genotyping Market
Chapter 4. North America Genotyping Market by Product
4.1 North America Reagents & Kits Market by Country
4.2 North America Instruments Market by Country
4.3 North America Software & Services Market by Country
Chapter 5. North America Genotyping Market by Application
5.1 North America Diagnostics & Personalized Medicine Market by Country
5.2 North America Agricultural Biotechnology Market by Country
5.3 North America Pharmacogenomics Market by Country
5.4 North America Animal Genetics Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Genotyping Market by End Use
6.1 North America Diagnostics & Research Laboratories Market by Country
6.2 North America Pharmaceutical & Biopharmaceutical Companies Market by Country
6.3 North America Academic Institutes Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Genotyping Market by Technology
7.1 North America PCR Market by Country
7.2 North America Sequencing Market by Country
7.3 North America Capillary Electrophoresis Market by Country
7.4 North America Microarray Market by Country
7.5 North America Mass Spectrometry Market by Country
7.6 North America Others Market by Country
Chapter 8. North America Genotyping Market by Country
8.1 US Genotyping Market
8.1.1 US Genotyping Market by Product
8.1.2 US Genotyping Market by Application
8.1.3 US Genotyping Market by End Use
8.1.4 US Genotyping Market by Technology
8.2 Canada Genotyping Market
8.2.1 Canada Genotyping Market by Product
8.2.2 Canada Genotyping Market by Application
8.2.3 Canada Genotyping Market by End Use
8.2.4 Canada Genotyping Market by Technology
8.3 Mexico Genotyping Market
8.3.1 Mexico Genotyping Market by Product
8.3.2 Mexico Genotyping Market by Application
8.3.3 Mexico Genotyping Market by End Use
8.3.4 Mexico Genotyping Market by Technology
8.4 Rest of North America Genotyping Market
8.4.1 Rest of North America Genotyping Market by Product
8.4.2 Rest of North America Genotyping Market by Application
8.4.3 Rest of North America Genotyping Market by End Use
8.4.4 Rest of North America Genotyping Market by Technology
Chapter 9. Company Profiles
9.1 F. Hoffmann-La Roche Ltd.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.1 Recent strategies and developments:
9.1.1.1 Partnerships, Collaborations, and Agreements:
9.2 Danaher Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.3 Agilent Technologies, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Thermo Fisher Scientific, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 Qiagen N.V.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.6 Illumina, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.7 Bio-Rad laboratories, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.8 Eurofins Scientific Group
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Acquisition and Mergers:
9.9 Fluidigm Corporation
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expenses
Unique Offerings 